According to the new market research report "Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecasts to 2028"
The global blood culture tests market size is projected to reach USD 6.1 billion by 2025, at a CAGR of 8.9%.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883
Drivers: High incidence of blood stream infections
Nosocomial (hospital-acquired) bloodstream infections are one of the important causes of death across the globe. In the US alone, nearly 250,000 cases of hospital-acquired bacterial blood stream infections (BSIs) occur each year. Bloodstream infections affect about 30 million people leading to 6 million deaths, with 3 million new-borns and 1.2 million children suffering from sepsis annually worldwide. In Eastern African countries, the ratio of patients with bloodstream infections is reported to range from 11 percent to 28 percent. Bloodstream infection rates are estimated to be in the scale of 9.3 percent to 11.2 percent in Ghana (Source: Journal of Tropical Medicine, 2019). The incidence of these infections raises the overall duration of hospitalization as well as the cost of treatment. With the high incidence of bacterial blood stream infections (BSIs), the need for advanced blood culture techniques that help in the early detection of infections is expected to increase.
Market key Players
The major players in the blood culture tests market are Becton, Dickinson and Company (US), bioMérieux SA (France), and Thermo Fisher Scientific Inc. (US). These companies together accounted for a share of more than 60% of the blood culture tests market in 2019. Other players in the market include Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (a subsidiary of Abbott Laboratories) (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India)among others.
Report Objectives
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East Africa)
- To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the 55 during the forecast period
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.marketsandmarkets.com/Market-Reports/blood-culture-test-market-159606753.html
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.
Get 10% Free Customization on this Report-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194978883
Company information
Detailed analysis and profiling of additional market players (up to 20)
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn, and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email: [email protected]
